Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Mol Aspects Med. 2021 Apr 28;82:100966. doi: 10.1016/j.mam.2021.100966

Table 1.

Mouse models implicating autophagy involvement in cardiovascular diseases

Disease model Genetic Intervention in mice Results Ref
Aging Atg5 transgene (Tg) overexpression Reduced age-related cardiac fibrosis, increased lifespan extension (Pyo et al., 2013)
BECN1F121A knockin Reduced age-associated cardiac alterations, increased lifespan (Fernández et al., 2018)
Prkn Tg overexpression Reduced age-associated cardiac abnormalities (Hoshino et al., 2013)
Atherosclerosis atg5 −/− Accelerated atherosclerosis (Liao et al., 2012b)
Cardiomyopathy Atg5 +/− Exacerbated cardiac hypertrophy (Zhao et al., 2014)
Atg7 Tg overexpression Reduced cardiac hypertrophy, limited intracellular protein aggregation, and increased mouse survival (Bhuiyan et al., 2013)
Becn1 +/− Accelerated heart failure (Tannous et al., 2008)
Becnl Tg overexpression Exacerbated pathogenic remodeling (Zhu et al., 2007)
Myocardial infarction Becn1 +/− Reduced cardiac damage at reperfusion (Matsui et al., 2007)
prkn −/−
prkn −/−
Exacerbated cardiac injury and reduced survival
Increased infarct size, hypertrophy
(Kubli et al., 2013)
atg5 −/− Increased sensitivity, exacerbated hypertrophy (Nakai et al., 2007)
I/R injury Becn1 +/− Cardioprotective during reperfusion (Matsui et al., 2007)
Pressure overload atg5 −/− Increased sensitivity, exacerbated hypertrophy (Nakai et al., 2007)
Becn1+/−
Becn1 Tg overexpression
Reduced pathological cardiac remodeling
Exacerbated pathological cardiac remodeling
(Zhu et al., 2007)
Sepsis Becn1 +/− Cardioprotective during reperfusion (Sun et al., 2018)